Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Lacripep by TearSolutions for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Lacripep is under clinical development by TearSolutions and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData,...
Data Insights
Lacripep by TearSolutions for Sicca Syndrome (Sjogren): Likelihood of Approval
Lacripep is under clinical development by TearSolutions and currently in Phase II for Sicca Syndrome (Sjogren). According to GlobalData, Phase...